Cargando…
Perception versus reality: A National Cohort Analysis of the surgery‐first approach for resectable pancreatic cancer
INTRODUCTION: Although surgical resection is necessary, it is not sufficient for long‐term survival in pancreatic ductal adenocarcinoma (PDAC). We sought to evaluate survival after up‐front surgery (UFS) in anatomically resectable PDAC in the context of three critical factors: (A) margin status; (B)...
Autores principales: | Bergquist, John R., Thiels, Cornelius A., Shubert, Christopher R., Ivanics, Tommy, Habermann, Elizabeth B., Vege, Santhi S., Grotz, Travis E., Cleary, Sean P., Smoot, Rory L., Kendrick, Michael L., Nagorney, David M., Truty, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419760/ https://www.ncbi.nlm.nih.gov/pubmed/34289264 http://dx.doi.org/10.1002/cam4.4144 |
Ejemplares similares
-
Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patients
por: Driedger, Michael R., et al.
Publicado: (2020) -
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors
por: Gudmundsdottir, Hallbera, et al.
Publicado: (2022) -
Yield of Staging Laparoscopy for Pancreatic Cancer in the Modern Era: Analysis of More than 1,000 Consecutive Patients
por: Gudmundsdottir, Hallbera, et al.
Publicado: (2023) -
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients
por: Gudmundsdottir, Hallbera, et al.
Publicado: (2023) -
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer
por: Alva-Ruiz, Roberto, et al.
Publicado: (2021)